Concepedia

CD70 antibody-drug conjugate as a potential therapeutic agent for uterine leiomyosarcoma

Ruriko Nakae, Shinya Matsuzaki, Shinya Matsuzaki, Satoshi Serada, Koji Matsuo, Mayu Shiomi, Kazuaki Sato, Yoshikazu Nagase, Satoko Matsuzaki, Satoko Matsuzaki,

American Journal of Obstetrics and Gynecology · 2020 · 11 citations · 36 references

DOI

Concepts

References

36

Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial

Winette T.A. van der Graaf, Jean‐Yves Blay, Sant P. Chawla et al. · The Lancet · 2012 · 2.1K citations · Full text

, , +9

Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial

Hussein A. Tawbi, Melissa Burgess, Vanessa Bolejack et al. · The Lancet Oncology · 2017 · 1.4K citations · Full text

, , +13

CD27 is required for generation and long-term maintenance of T cell immunity

Jenny Hendriks, Loes A. Gravestein, Kiki Tesselaar et al. · Nature Immunology · 2000 · 794 citations

, , +14

Intracellular Released Payload Influences Potency and Bystander-Killing Effects of Antibody-Drug Conjugates in Preclinical Models

Li Fu, Kim K. Emmerton, Mechthild Jonas et al. · Cancer Research · 2016 · 321 citations

, , +17

Molecular and biological characterization of a ligand for CD27 defines a new family of cytokines with homology to tumor necrosis factor

Raymond G. Goodwin, Mark R. Alderson, Craig A. Smith et al. · Cell · 1993 · 277 citations

, , +11